Medical management is the primary treatment modality; however, if there is progression of the disease that causes visual impairment, surgical debulking is often required. Treatment options for Morbihan disease reported in the literature include isotretinoin, systemic antibiotics (tetracyclines, metronidazole), antihistamines (ketotifen), systemic corticosteroids, clofazimine and thalidomide which generally overlap with the management of rosacea. 1-3 We report two such cases of Morbihan syndrome in patients that responded well to treatment with a combination of 2.5% hydrocortisone cream . Dr. David Cohen is a Dermatologist in New York, NY. . Morbihan disease is frequently refractory to treatment. Although its etiology is poorly understood, it is known to have a wide differential diagnosis and is frequently under-recognized. 1 It is unclear whether MMS is a disease that affects fair-skinned people of Caucasian or Northern European . The majority of patients were male (80%), and the mean age at presentation was 67 years (range, 48-88 years); 60% had asymmetrical disease (affecting mainly the right side). By Falk Georges Bechara, Thomas Jansen, . OLVERA-CORTS V, PULIDO-DAZ N. Effective Treatment of Morbihan's Disease with Long . Its cause remains unclear. Morbihan disease (MD) is a rare form of rosacea that presents with chronic erythema and solid oedema on the upper half of the face. Granulomatous rosacea is a type of rosacea that occurs mainly around the cheeks, eyes, and mouth. If you have a fatty liver you need more of it. Rosacea is common and is characterised by persistent facial redness. Morbihan disease is classified as a special form of rosacea, which presents with persistent facial erythema and solid edema because of marked involvement of the lymphatic vessels. Rosacea is a chronic inflammatory skin condition predominantly affecting the central face and most often starts between the age of 30-60 years. A diagnosis of MD can be made only after eliminating diseases that are similar in terms of clinical and histopathological presentation. It is considered a clinical variety or a complication of acne or rosacea. What can I do to treat rosacea? The ALS Therapy Development Institute is unbiased in our listing of clinical trials and provides information on all those enrolling worldwide. 2019;35(2):126-132. The Human Phenotype Ontology in 2021, Nucleic Acids Research, Volume 49, Issue D1, 8 January 2021, Pages D1207-D1217. Find Dr. Cohen's phone number, address, hospital affiliations and more. Based on these results, this new regimen in the therapeutic approach toward Morbihan disease is suggested due to its anti-inflammatory features and low risk of side effects. The reality is that the prevalence of rosacea in SOC is not well characterized but is . Please protect yourself from ignorant doctors and BS 'cure' pseudoscience from people on the internet. This main symptom is nicknamed "Grover's rash.". This patient also suffered from vitiligo; for which he was being treated . Anti-inflammatory ingredients are often the most useful when treating rosacea. The symptoms include yellowish-brown or pink bumps ( papules) on the skin, thickening of the skin, and patchy redness. pinarborman@gmail.com; Faculty of Medicine, Ankara City Hospital/Department of Physical Medicine and Rehabilitation, University of Health Sciences, Ankara, Turkey. It is resistant to treatment; diagnosis could be difficult. Methods Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review of the literature was performed on April 1, 2018, using PubMed, Google Scholar, and Excerpta Medica dataBASE with terms used to describe Morbihan disease, including "Morbihan Disease," "Morbihan Syndrome . 2010;23:682-5. Rosacea is usually diagnosed clinically except in cases of granulomatous rosacea where a skin biopsy is necessary. With our current understanding, we can undertake to define treatment targets based on clinical data and the current conception of physiopathology. . Treatment options for Morbihan disease reported in the literature include isotretinoin, systemic antibiotics (tetracyclines, metronidazole), antihistamines (ketotifen), systemic corticosteroids, clofazimine and thalidomide which generally overlap with the management of rosacea. Morbihan syndrome (MS) is a rare condition that is considered either a subtype (1) or a late-stage complication of rosacea (2). Abstract. Facial lymphedema is an infrequent condition that is often caused by treatment for head and neck cancer. The cause of MD remains unclear and no standardised treatment is yet available. AIM: We report three new cases of solid persistent facial oedema, which, after treatment with furosemide, showed dramatic improvement. Citation: Zhou LF, Lu R. Successful treatment of Morbihan disease with total glucosides of paeony: A case report. The cheeks, nose and forehead are particularly affected. This refractory condition has been also designated as 'rosacea lymphoedema' and 'solid persistent facial oedema of rosacea'. All subjects underwent a lid biopsy to support the diagnosis of Morbihan syndrome, which showed features of inflammation and vascular dysfunction, highly suggestive of a . Its cause remains unclear. The antibiotic metronidazole and the tetracyclines, minocycline and doxycycline, are effective for inflammatory rosacea. Treatment of Morbihan's disease is challenging due to its nonspecific etiology and lack of treatment consensus. The treatment of Morbihan disease with total glucosides of paeony has not previously been reported. If you have a chronic inflammatory condition such as allergies, autoimmune disease, asthma or skin problems, you need more glutathione. 48 years old male patient applied to our polyclinic with complaint of swelling on left side of his face, around his eye and cheeks, persistent for 6 months. It is believed to be a complication of rosacea and may occur at any stage of the disease. Summary Morbihan disease is a rare complication of rosacea, characterized by persistent lymphoedema on the upper half of the face, occurring during the chronic clinical course of rosacea. We report a case of a 51-year-old patient consulted in our department for a one year facial edema, erythema and papules reported by him, for which the patient was treated with cyclins, local and general corticotherapy, without improvement. 1 Even though acne rosacea responds well to standard medical treatment, the lymphedema component of the disease is resistant to . Successful treatment of Morbihan's diseast with oral prednisolone and doxycycline. Glutathione is your liver's most powerful detoxifier and it is strongly anti-inflammatory. G. Chaidemenos, Corresponding Author. It is believed to be due to lymphatic obstruction. Morbihan syndrome is a rare entity characterized by persistent erythema and solid edema of upper two-thirds of the face. Grover's disease is a rare skin condition. PURPOSE: To assess the effectiveness of treatments for Morbihan disease. Classifications of rosacea have also . Morbihan syndrome is a rare entity characterized clinically by chronic erythematous edema localized exclusively on the forehead, glabella, eyelids, and cheeks. MD in patients of skin of color may be underreported as well as underdiagnosed . Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase . Reported therapy includes short-term oral isotretinoin (0.5 mg/kg/day), long-term oral isotretinoin (40-80 mg/day, 10-24 months), long-term . Many different systemic and even surgical treatment approaches have been used with variable results. . Isotretinoin can be good choice . Search for more papers by this author. This treatment can be continued safely for months or years if your acne remains active. Rosacea is usually diagnosed by the typical . I'm unable to go outside in the sun anymore. Morbihan disease (MD) is a rare entity. Morbihan disease, also known as rosacea lymphedema, is a rare and persistent form of lymphedema associated with acne rosacea. Treatment of Morbihan disease Arch Craniofac Surg. Morbihan disease (MD), also known as solid persistent facial edema, lymphedema rosacea, morbus Morbihan and Morbihan syndrome, is a rare condition characterized by chronic, progressive, non-pitting edema (+/- erythema) of the upper two-thirds of the face, notably the periorbital tissue, forehead, glabella, nose, and cheeks, that may result in . Most people with this condition get red, itchy spots, but others get blisters. MD often tends to be recalcitrant to therapies . Hospital of skin and Venereal Diseases, Thessaloniki, Greece. [15313] The cause of granulomatous rosacea is unknown, but both genetic and non-genetic factors contribute to this condition. 1-3 We report two such cases of Morbihan syndrome in patients that responded well to treatment with a combination of 2.5% hydrocortisone cream . We report a case of a 51-year-old patient consulted in our department for a one year facial edema, erythema and papules reported by him, for which the patient was treated with cyclins, local and general corticotherapy, without improvement. The rash normally . The evaluation, diagnosis and treatment of this condition are hugely complicated. International audienceBACKGROUND: Morbihan's disease (MD), also known as 'persistent facial oedema' or 'rosaceous lymphoedema', is an uncommon facial condition that is difficult to treat. Purpose: To assess the effectiveness of treatments for Morbihan disease. Recently, MD has been reported to be associated with the infiltration of mast cells. Persistent facial swelling can occur as a rare complication of rosacea. 1 It is characterized by a nonpitting and nontender chronic erythematous lymphedema of the forehead, glabella, eyelids, nose, and cheeks. This condition is also known as chronic upper facial erythematous edema, Morbihan's disease, morbus Morbihan, and rosaceous lymphedema. Morbihan disease: a therapeutic challenge 849 Figure 3A: Excellent improvement of erythema Figure 3B: Side view of the face after the first month of treatment and lymphedema after a month of treatment with isotretinoin and deflazacort is early involved in the pathogenesis of rosacea.6 reported.1 Although about 20% of patients may not respond to . Background: Morbihan's disease (MD), also known as 'persistent facial oedema' or 'rosaceous lymphoedema', is an uncommon facial condition that is difficult to treat. Specialists evaluated the treatment's success by photodocumentation and measured a 91.5% alleviation of erythema, and 85% reduction of edema, respectively. The syndrome was . also reported the formation of granulomas around dilated lymphatic vessels and luminal obstruction by histiocytic infiltration. We report a patient with Morbihan disease showing persistent lymphoedema on . Isotretinoin, ketotifen and oral corticosteroids are the most useful treatments reported.3. This . We encourage you to browse trials below and subscribe to our clinical trials email to receive monthly updates with changes to trials listed in this database. Morbihan disease or oedematous rosacea is characterized by persistent red swollen skin on the face. Morbihan Disease - An Old and Rare Entity Still Difficult to Treat // Acta dermatovenerologica Croatica, 28 (2020), 2; 119-120 (meunarodna recenzija, pismo uredniku, struni) Morbihan Morbihan diseaseSolid facial edema . 2 2 Smith LA, Cohen DE. Purpose To assess the effectiveness of treatments for Morbihan disease. Morbihan disease is a rare entity characterised by the development of erythema and solid oedema in the middle and upper third of the face. Successful Long-term Use of Oral Isotretinoin for the Management . Morbihan syndrome who underwent with any treatment regi-men found that 72% experienced at least partial response and 14% experiencing complete resolution of disease. 2012;148(012):1395-1398. Introduction Morbihan disease is a condition of unclear aetiology characterised by solid facial swelling, usually in the upper and middle parts of the face. Methods Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review of the literature was performed on April 1, 2018, using PubMed, Google Scholar, and Excerpta Medica dataBASE with terms used to describe Morbihan disease, including "Morbihan Disease," "Morbihan Syndrome . Oral isotretinoin was ineffective despite the relatively long duration of the therapy (26 weeks), and Histopathological examination showed dermal edema, perivascular and periadnexal lympho-histiocytic infiltrate, and sebaceous gland hyperplasia. However, every attempt should be made to provide treatment because . Data from the National Center for Biotechnology Information's MedGen is used to provide genetic testing information available for a disease. Morbihan disease treatment: two case reports and a systematic literature review. Dr. Edward J. Wladis is a Ophthalmologist in Slingerlands, NY. Because of few related imaging reports, Morbihan syndrome is likely to be misdiagnosed, which delays the treatment to cause syndrome progression. 2010; 23(6): 6825. Dermatol Ther 2010; 23: 682-685. Morbus Morbihan Syndrome (MMS), defined by Robert Degos in 1957, is a disease characterized by chronic recurrent erythema, edema, and persistent swelling in the central upper and midline of the face and consequently results in fibrotic tissue development in these areas. Reference: MedGen Data Downloads and FTP. World J Clin Cases 2022; In press: Received: 2022-01-13 04:31: Peer-Review Started: We report a case of a 45yearold male with no pre. There's no permanent cure but . Purpose To assess the effectiveness of treatments for Morbihan disease. Covering nearly 260 of the most common dermatologic conditions from A to Z, Treatment of Skin Disease, 6th Edition, by Drs. In this report, we describe a case of Morbihan disease in a 32-year-old man. We report a new case of MD. Solid facial oedema/head and neck lymphoedema (an umbrella term, which includes Morbihan disease and any other causes of persistent facial oedema) generally presents as a persistent, non-pitting, asymptomatic, symmetrical swelling. Morbihan's disease: treatment with CO2 laser blepharoplasty . . Case reports or case series were included if they fulfilled the following criteria: published in English, peer-reviewed, and reported Morbihan disease. Be safe. Pnar Borman MD, Corresponding Author. Ranu H., Lee J., Hee T.H. Learn how you can help rosacea . Neither laboratory nor instrumental abnormalities are observed. Successful treatment for the different and rare cause of facial lymphedema: Morbus Morbihan disease. Treatment of Morbihan's disease can be difcult at times with different therapeutic modalities having variable and to some extent unpredictable outcomes. Caucasian adults of both sexes are affected. . What is the treatment for Morbihan disease? Like x 3; Informative x 1; Detroit Guy, Jan 26, 2021 #7. twa Member Benefactor . Abstract. Because rosacea can have a nuanced presentation in skin of color (SOC), with erythema and telangiectasias that may be difficult to discern in the setting of increased background pigmentation, it was incorrectly assumed for a long time to simply not be there. The azelaic cream is also effective for mild inflammatory rosacea if applied twice daily to affected areas. . This finding is referred to as lymphedematous rosacea or Morbihan's disease. It typically has a relapsing and remitting course, with symptoms controlled by lifestyle measures, general skin care, medications . Ophthalmic Plastic & Reconstructive Surgery. Br J Dermatol . Request PDF | Morbihan Disease | Morbihan disease (MD), also known as solid persistent facial edema, lymphedema rosacea, morbus Morbihan and Morbihan syndrome, is a rare condition. A case series report and review of the literature. Therapy. Find Dr. Wladis's phone number, address, insurance information, hospital affiliations and more. First published: 17 August 2017. Although the symptoms may come and go, MD usually does not improve without treatment (5). edica dataBASE with terms used to describe Morbihan disease, including "Morbihan Disease," "Morbihan Syndrome," "lymphedema rosacea," and "lymphedematous rosacea". Mazzatenta C, Giorgino G, Rubegni P, de Aloe G, Fimiani M. Solid persistent facial oedema (Morbihan's disease) following rosacea, successfully treated with isotretinoin and ketotifen. Introduction. Although its etiology is poorly understood, it is known to have a wide differential diagnosis and is frequently under-recognized. Results: A total of 89 patients87 patients from 49 articles . It typically affects the periorbital region, forehead, glabella, nose, and cheeks. Dermatol Ther. Currently, the treatment options of this cosmetically very disturbing disease are limited. Because of a significant exacerbation of skin lesions, treatment with isotretinoin and . Other options are: Isotretinoin 10-20 mg daily for 3-6 months; Ketotifen 1 mg daily [6]. I interviewed Dr. Kimberly Huerth on her poster presentation of an African-American man with long-standing, progressive Morbihan Disease that took 16 years to diagnose. Definitive treatment options are also lacking, and most current topical, systemic, and surgical interventions provide transient or partial results. Currently, there is no established standard treatment for MD. Successful treatment of Morbihan's disease with oral prednisolone and doxycycline. Morbihan disease affects Caucasian adults of both genders and is considered by most authors as a clinical variety or complica-tion of acne or rosacea. Morbihan disease is considered to be an idiopathic form of solid facial edema [15, 22, 23, 24]. The cause of MD remains unclear and no standardised treatment is yet available. This award-winning text provides guidance on the . Therapeutic hotline: Successful treatment of Morbihan's disease with oral prednisolone and doxycycline. Epub . While its pathogenesis is not fully known, it is characterised by the clinical features of erythema and overt oedema of the upper two-thirds of the face. Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. Morbihan disease, which consists of solid facial edema, is a rare complication of rosacea, a common cutaneous disorder in middle-aged individuals. However, men with Morbihan syndrome have been shown to have a decreased likelihood of disease resolution with treatment.4 While both our patients were male, our second patient pre- We herein report a case of Morbihan syndrome with bilateral periorbital masses causing pupillary axis obstruction, and carefully analyze the clinical features, imaging information, histopathology, and . The disease may develop as a complication of rosacea, with intense erythema and telangiectasias. With the first verifiable appearance of the nomenclature dated back to Robert Degos from France in 1973, Morbihan disease remains obscure regarding its epidemiology, etiopathogenesis, treatment . Medical treatments. Several therapeutic options have been reported, although there is no established standard treatment for MD. Doctors treat Morbihan disease with steroids and sometimes minor surgery to drain the excess fluid. . Mark G. Lebwohl, Warren R. Heymann, Ian Coulson, and Dedee Murrell, is your go-to resource for authoritative, evidence-based treatment strategies in your daily practice. Morbihan's disease, PERSISTENT ERYTHEMA, rosacea . Dermatol. Morbihan disease: successful treatment with slow-releasing doxycycline monohydrate. We report a case of severe Morbihan syndrome (chronic erythematous edema of the upper portion of the face) in a 60-year-old man. Morbihan syndrome is a rare entity characterized by persistent erythema and solid edema of upper two-thirds of the face. Emerging novel therapeutic agents for the treatment of patients with prurigo nodularis. Aim: We report three new cases of solid persistent facial oedema, which, after treatment with furosemide, showed dramatic improvement. Morbihan Disease (MD) is a rare condition but can be a very rewarding diagnosis to make. Tanaka T. Successful treatment of Morbihan Disease with long . Persistent edema of rosacea is an uncommon cutaneous condition characterized by a hard, nonpitting edema restricted to the forehead, glabella, upper eyelids, nose, and cheeks. Smith LA, Cohen DE. Its nosography is unclear and its therapeutic management is difficult. Morbihan disease is classified as a special form of rosacea, which presents with persistent facial erythema and solid edema because of marked involvement of the lymphatic vessels. 12. Treatment. Currently, the treatment options of this cosmetically very disturbing disease are limited. Morbihan disease (MD) is a rare entity. If left untreated, rosacea can lead to more serious symptoms 2 like the thickening and hardening of skin on the nose and eyelids, or even persistent swelling in the upper portion of the face (also known as Morbihan disease 1). 2021 Jun;22(3):131-134. doi: 10.7181/acfs.2021.00185. Morbihan disease (MD) is a rare form of rosacea that presents with chronic erythema and solid oedema on the upper half of the face. Arch Dermatol. However, it is unclear whether it is a distinct disease and may occur in patients without clinical manifestations of rosacea.2,3 The term "Morbihan" refers to a district of France where A person can experience eye swelling in both eyes due to organ failure. Its nosography is unclear and its therapeutic management is difficult. Organ failure. Therapeutic options for the disease remain unsatisfactory and treatments reported in the literature include systemic glucocorticoids, oral tetracyclines, thalidomide, isotretinoin, ketotifen, and . Persistent redness and swelling of the upper face due to lymphatic obstruction (Morbihan disease) . cgiorgos@otenet.gr; Dermatology, Private Office, Thessaloniki, Greece. The challenge lies in choosing the right treatment that presents a successful and lasting response. We present a case of Morbihan's disease in a 57 year old man with a skin type IV and the challenges of treatment. We present the first reported case of Morbihan's disease in a Navajo patient in conjunction with a review of the literature on surgical management of this challenging disease. Morbihan disease (MD) is rosacea-like disease characterized by persistent lymphedema on the upper half of the face. The involvement of innate immunity in rosacea, which was previously considered an inflammatory but mainly vascular disease, was the main finding of the 2000s [2]. Successful long-term use of oral isotretinoin for the management of Morbihan disease. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review of the literature was performed on April 1, 2018, using PubMed, Google Scholar, and Excerpta Medica dataBASE with terms used to describe Morbihan disease, including "Morbihan Disease," "Morbihan . Nagasaka et al. Solid persistent facial edema is a rare and poorly understood condition that is difficult to treat and can lead to significant cosmetic disfigurement, adversely affecting a patient's self-esteem and mental health.1 It can be a serious complication of acne vulgaris and rosacea, but also may be associated with other congenital, infectious, malignant, and inflammatory processes.2 It has also been . Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. We report a new case of MD. He suffered from erythema and swelling over the left periorbital region for 6 years, and was diagnosed with Morbihan disease. A study by Wohlrab et al., however, showed that Morbihan disease may be attributed to a combination of poor lymphatic drainage and subclinical inflammation from immunologic contact urticaria . | Find, read . A diagnosis of MD can be made only after eliminating diseases that are similar in terms of clinical and histopathological presentation. Morbus Morbihan disease is granulomatous complication characterized with facial edema occuring due to acne or rosacea. The cheeks, nose and forehead are particularly affected. It caused a condition called Morbihan disease, leaving my face permanently swollen, red and burning. METHODS: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review of the literature was performed on April 1, 2018, using PubMed, Google Scholar, and Excerpta Medica dataBASE with terms used to describe Morbihan . Treatment options for Morbihan disease reported in the literature are isotretinoin, systemic antibiotics (tetracyclines .